Sentences with phrase «pimobendan lived»

In a study completed in the UK, Doberman Pinschers treated with pimobendan lived 6 times longer than those treated with an ACE inhibitor (329 days vs 50 days).7
Dogs treated with pimobendan lived almost twice as long as dogs treated with an ACE inhibitor (267 days vs 140 days).2

Not exact matches

In a study of Doberman Pinschers, 80 % of the dogs treated with pimobendan showed improvements in the quality ‑ of ‑ life measures (including exercise tolerance, coughing, dyspnea, and fatigue) compared with only 10 % in the group not treated with pimobendan.7
In the EPIC Study, dogs in the pimobendan group experienced 10 % more life without congestive heart failure (CHF) signs that impact quality of life (10 % more life without CHF was calculated based on an estimated lifespan for all small to medium ‑ sized dogs being 12.5 years.
In the VetSCOPE Study, pimobendan rapidly improved the quality of life in dogs with CHF caused by myxomatous mitral valve disease (MMVD).
QUEST stands for Quality of Life and Extension of Survival Time, and was an international, multi-centre clinical study comparing 2 treatments used to combat CHF in dogs, pimobendan and an ACE inhibitor (benazepril hydrochloride).2
Pimobendan also significantly improves the quality of life in dogs with CHF caused by DCM.
In the EPIC Study, dogs in the pimobendan group experienced 60 % more time in asymptomatic stage B2 of heart disease and 10 % more life without CHF signs that impact quality of life (10 % more life without CHF was calculated based on an estimated lifespan for all small to medium ‑ sized dogs being 12.5 years.
Patients in Dr. Tyrell's practice have gotten years of quality life because of treatment with Pimobendan, and one study suggests its use in the IWH prior to the onset of congestive heart failure.
The EPIC study (Evaluation of Pimobendan In Cardiomegaly) found pimobendan extended the asymptomatic period by an average of 15 months, while dogs that received the drug also lived significantly longer than those receiving Pimobendan In Cardiomegaly) found pimobendan extended the asymptomatic period by an average of 15 months, while dogs that received the drug also lived significantly longer than those receiving pimobendan extended the asymptomatic period by an average of 15 months, while dogs that received the drug also lived significantly longer than those receiving a placebo.
a b c d e f g h i j k l m n o p q r s t u v w x y z